Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
73,174,000
-
Share change
-
-177,113
-
Total reported value
-
$39,723,882,129
-
Put/Call ratio
-
146%
-
Price per share
-
$542.87
-
Number of holders
-
572
-
Value change
-
-$79,287,903
-
Number of buys
-
272
-
Number of sells
-
252
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2015
As of 31 Dec 2015 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 572 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 73,174,000 shares of stock of the company.
Largest 10 holders included Capital World Investors, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, JPMORGAN CHASE & CO, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC.
This table shows 573 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.